Parker Flex-it Stylet Versus Malleable Stylet in Orotracheal Intubation Using a Fiber-optic Laryngoscope

April 15, 2022 updated by: Damanhour Teaching Hospital

Parker Flex-it Directional Stylet Versus Conventional Malleable Stylet in Elective Orotracheal Intubation Using a Fiber-optic Laryngoscope

Objectives: To compare the safety and efficacy of Parker flex-it directional stylet (PFDS) versus conventional malleable stylet (CMS) in orotracheal intubation (OTI) using fiber-optic Macintosh laryngoscope.

Background: OTI is used in general anesthesia for anesthetic delivery and ventilation of patients. OTI delay or failure may adversely affect patient outcomes, therefore, anesthetists with sufficient clinical experience and skill should perform OTI. However, in emergency situations, experienced anesthetists may not be available, and the patient may have a high Cormack-Lehane grade. A stylet is commonly used in the emergency department to aid insertion of the endotracheal tube during direct laryngoscopy.

Patients and Methods: This was a prospective, randomized, double-blind clinical trial; carried out on 80 patients requiring OTI under general anesthesia at our hospital. Patients were randomly allocated into two equal groups; group DS, intubated using PFDS, and group MS, intubated using CMS.

Study Overview

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • El-Beheira
      • Damanhūr, El-Beheira, Egypt
        • Damanhour Teaching Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 58 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • American Society of Anesthesiologists (ASA) physical status ≤ II
  • Age from 21 to 60 years
  • Body Mass Index (BMI) < 35
  • Mallampati classification ≤ II

Exclusion Criteria:

  • American Society of Anesthesiologists (ASA) physical status > II
  • Age < 21 years or > 60 years
  • Body Mass Index (BMI) ≥ 35
  • Mallampati classification > II
  • Pregnant women
  • Anticipated difficult airway
  • Need for rapid sequence induction
  • Increased risk of gastric aspiration such as gastroesophageal reflux
  • Edentulous patients, Loose teeth
  • Known pathology, trauma, or previous surgery to the mouth, pharynx, larynx, or cervical spine
  • History of; Dysrhythmia, Hypertension, Ischemic heart disease, Hyperthyroidism, DM

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group DS (n=40)
Parker Flex-it Directional Stylet group
Parker Flex-it Directional Stylet
Active Comparator: Group MS (n=40)
Conventional Malleable Stylet group
Conventional Malleable Stylet

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean and Standard deviation of Time required for orotracheal intubation (seconds) (mean±SD)
Time Frame: 2 minutes after inserting the blade of the laryngoscope in the mouth
Time interval from holding the endotracheal tube by the anesthetist till removal of the stylet from the endotracheal tube by the anesthetist
2 minutes after inserting the blade of the laryngoscope in the mouth

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean and Standard deviation of Total time required for orotracheal intubation (seconds) (mean±SD)
Time Frame: 2 minutes after inserting the blade of the laryngoscope in the mouth
Time interval from inserting the blade of the laryngoscope into the patient's mouth till the appearance of end-tidal carbon dioxide curve of at least 30 mmHg on the anesthesia monitor after insertion of the endotracheal tube
2 minutes after inserting the blade of the laryngoscope in the mouth
Mean and Standard deviation of Number of intubation attempts (mean±SD)
Time Frame: 2 minutes after inserting the blade of the laryngoscope in the mouth
An attempt is the act of inserting and removing the blade of the laryngoscope from the mouth
2 minutes after inserting the blade of the laryngoscope in the mouth
Number of participants and Rate of Successful intubation from the first-attempt
Time Frame: 2 minutes after inserting the blade of the laryngoscope in the mouth
First-attempt intubation success rate
2 minutes after inserting the blade of the laryngoscope in the mouth
Number of participants and Rate of Use of external laryngeal manipulation
Time Frame: 2 minutes after inserting the blade of the laryngoscope in the mouth
Number of participants and Rate of Use of external laryngeal manipulation
2 minutes after inserting the blade of the laryngoscope in the mouth
Mean and Standard deviation of Heart rate (beat/min.)(mean±SD)
Time Frame: 2 minutes after inserting the blade of the laryngoscope in the mouth
Before, after induction, and 2 minutes after inserting the blade of the laryngoscope in the mouth
2 minutes after inserting the blade of the laryngoscope in the mouth
Mean and Standard deviation of Oxygen Saturation (%)(mean±SD)
Time Frame: 2 minutes after inserting the blade of the laryngoscope in the mouth
Before, after induction, and 2 minutes after inserting the blade of the laryngoscope in the mouth
2 minutes after inserting the blade of the laryngoscope in the mouth
Mean and Standard deviation of Blood Pressure (mmHg)(mean±SD)
Time Frame: 2 minutes after inserting the blade of the laryngoscope in the mouth
Before, after induction, and 2 minutes after inserting the blade of the laryngoscope in the mouth
2 minutes after inserting the blade of the laryngoscope in the mouth
Number of participants and Rate of Procedure-related complications
Time Frame: 5 minutes after the end of the procedure
Number of participants and Rate of: Tachycardia, Dysrhythmia, Hypoxemia, Hypertension, Laryngospasm, Bronchospasm, Oropharyngeal trauma
5 minutes after the end of the procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2021

Primary Completion (Actual)

March 15, 2022

Study Completion (Actual)

March 15, 2022

Study Registration Dates

First Submitted

April 21, 2021

First Submitted That Met QC Criteria

April 21, 2021

First Posted (Actual)

April 23, 2021

Study Record Updates

Last Update Posted (Actual)

April 22, 2022

Last Update Submitted That Met QC Criteria

April 15, 2022

Last Verified

April 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Orotracheal Intubation

Clinical Trials on Parker Flex-it Directional Stylet

3
Subscribe